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Abstract 
Introduction: Patients with schizophrenia (SZ) have deficits of facial emotion processing 
and cognitive inhibition, but the brain pathophysiology underlying these deficits and their 
interaction are not clearly understood. We tested brain activity during an emotional face 
go/no-go task that requires rapid executive control affected by emotional stimuli in 
patients with SZ using functional near-infrared spectroscopy (fNIRS).  
Methods: Twenty-five patients with SZ and 28 healthy control subjects were studied. We 
evaluated behavioral performance and used fNIRS to measure oxygenated hemoglobin 
concentration changes in fronto-temporal areas during the emotional go/no-go task with 
emotional and non-emotional blocks. 
Results: Patients with SZ made more errors and had longer reaction times in both test 
blocks compared with healthy subjects. Significantly greater activation in the inferior, 
superior, middle, and orbital frontal regions were observed in healthy subjects during the 
emotional go/no-go block compared to the non-emotional go/no-go block, but this 
difference was not observed in patients with SZ. Relative to healthy subjects, patients 
with SZ showed less activation in the superior and orbital frontal and middle temporal 
regions during the emotional go/no-go block.  
Discussion: Our results suggest that fronto-temporal dysfunction in patients with SZ is 
due to an interaction between abnormal processing of emotional facial expressions with 
negative valence and cognitive inhibition, especially during the rapid selection of rule-
based associations that override automatic emotional response tendencies. They indicate 
that fronto-temporal dysfunction is involved in the pathophysiology of emotional-
cognitive deficits in patients with SZ. 
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1 Introduction 
Patients with schizophrenia (SZ) have been shown to have abnormalities of face 
perception and emotional face processing in behavioral and neuroimaging studies 
(Marwick and Hall, 2008; Tremeau, 2006, for review). Emotional processing deficits 
involving social cognition are associated with poor functional outcomes (Hooker and 
Park, 2002) and negative symptoms (Chan et al., 2010) in patients with SZ. Behavioral 
studies suggest that patients with SZ tend to misinterpret neutral faces as negative 
emotional faces (Cohen et al., 2010; Habel et al., 2010; Kohler et al., 2003) and are 
impaired in processing emotional aspects of facial expressions affected for specificity 
(correct rejection of a non-target emotion) but not sensitivity (correct identification of a 
target emotion) (Habel et al., 2010; Schneider et al., 2006; Seiferth et al., 2009).  
Several brain regions are thought to be involved in face recognition: the inferior occipital 
gyrus for early perception of facial features; the superior temporal sulcus for changeable 
aspects of face-perception; the lateral fusiform gyrus for invariant aspects of face-
perception; the amygdala, insula, and limbic system for assessment of emotion; the 
anterior temporal cortex for personal identity, name, and biographical information (Haxby 
et al., 2000); and the prefrontal and orbitofrontal cortices for appraising the emotional 
significance of stimuli and guiding social decisions and behavior (Adolphs et al., 2000; 
Damasio, 2005). A meta-analysis of functional neuroimaging studies revealed that 
patients with SZ showed remarkable under-recruitment of the superior frontal gyrus, 
parahippocampus, amygdala, and middle occipital gyrus in response to emotional faces 
(Li et al., 2010) and increased activity in the dorsolateral prefrontal cortex, middle orbital 
gyrus (Habel et al., 2010), amygdala (Hall et al., 2008; Holt et al., 2006) and 
parahippocampus (Surguladze et al., 2006) in response to neutral faces. Such differences 
might be a consequence of aberrant attribution of emotional meaning to neutral stimuli 
(Habel et al., 2010). 
Patients with SZ are also less able to control cognitive inhibition. In functional magnetic 
resonance imaging (fMRI) studies during cognitive inhibition tasks (e.g., go/no-go) 
patients with SZ showed hypoactivation of the dorsolateral and ventrolateral prefrontal 
cortices and dorsal anterior cingulate cortex and hyperactivation of the superior parietal 
lobule compared to healthy subjects (Arce et al., 2006; Kaladjian et al., 2007; Kiehl et al., 
2000; Laurens et al., 2003). In a functional near-infrared spectroscopy (fNIRS) study, 
patients with SZ had greater activation of post-central region compared to healthy 
subjects during a go/no-go task (Nishimura et al., 2011). 
The interaction between emotional processing and cognitive function was impaired in 
patients with SZ, which contributed to poor social functioning (Park et al., 2008). Prior 
fMRI studies of emotional-cognitive interaction in patients with SZ employed a Stroop 
task with emotional pictures or go/no-go task with emotional words and suggested that 
SZ was characterized by inefficient top-down control and an association of dorsal and 
ventral frontal brain regions (Park et al., 2008; Vercammen et al., 2012). However, to our 
knowledge, no neuroimaging study has assessed the interaction between emotional face 
recognition and cognitive inhibition in patients with SZ. The interaction is useful for 
evaluating emotional control accompanied by social-cognitive interactions that require 
the rapid selection of rule-based associations that override automatic emotional response 
tendencies (Volman, 2011). The present study used an emotional go/no-go task with 
emotional faces combined with cognitive inhibition. This task was also expected to 
elucidate the subjects’ ability to correctly reject irrelevant emotional information that 
could alter target emotion processing, which has been reported to be affected in patients 
with SZ (Habel et al., 2010; Schneider et al., 2006; Seiferth et al., 2009).  
Near-infrared spectroscopy (NIRS) is a technology that assesses brain function; it 
measures real-time hemodynamics over the surface of the prefrontal cortex with infrared 
spectrum light. The signals measured by functional NIRS (fNIRS) correlate strongly with 
those measured by fMRI (Huppert et al., 2006; Toronov et al., 2001). The fNIRS 
instrument is small, convenient, noninvasive, is relatively insensitive to motion artifacts, 
and can be used in a natural seated position without any noise or pain. These advantages 
make it suitable to assess brain function in adults with psychiatric disorders such as 
schizophrenia (Takei, et al., 2013; Takizawa, et al., 2008) and mood disorders (Matsubara, 
et al., 2014; Matsuo, et al., 2007). In the content of social cognition, Takei et al. (2013) 
investigated brain activation during a face-to-face conversation task in patients with SZ 
and found decreased activation in the temporal lobes and the right inferior frontal gyrus. 
However, to our knowledge, there are no fNIRS studies that have investigated the 
interaction between emotional face recognition and cognitive inhibition in patients with 
SZ. 
Here, we examined brain activation in patients with SZ during an emotional go/no-go 
task using multi-channel fNIRS. Based on the findings of previous neuroimaging studies, 
we hypothesized that patients with SZ would show inferior behavioral performance and 
blunted activation of fronto-temporal regions during the task. 
2 Materials and Methods 
2.1 Subjects 
 A total of 53 individuals matched for age, sex, handedness, and premorbid intelligence 
quotient (IQ) participated in this study, including 25 patients with SZ diagnosed according 
to the Diagnostic and Statistical Manual of Mental Disorders IV, Text Revision (DSM-
IV-TR) (American Psychiatric Association, 2000) and 28 healthy subjects (Table 1). The 
patients included outpatients and inpatients being treated at Yamaguchi University 
Hospital and Katakura Hospital. Healthy subjects were recruited by advertisements and 
word-of-mouth in the community. This study was approved by the Institutional Review 
Board of Yamaguchi University Hospital and the ethics committee of Katakura Hospital. 
After the study was fully described to each subject, we obtained written informed consent 
from all participants. Patients were diagnosed using a clinical interview, scores on the 
Mini-International Neuropsychiatric Interview (M.I.N.I., Japanese version 5.0.0) (Otsubo 
et al., 2005), and conferences among psychiatrists. All patients were medicated with first-
generation antipsychotics (n = 1), second-generation antipsychotics (n = 13), or both (n = 
11). Doses of medication prescribed for the patients at the time of study participation were 
converted into chlorpromazine-equivalents (CPZ-eq). The Positive and Negative 
Syndrome Scale (PANSS, Kay et al., 1987) was used to assess psychiatric symptoms. We 
used a five-factor model of PANSS comprising 20 items categorized into Positive, 
Negative, Disorganized/Concrete, Excited, and Depressed factors (Wallwork et al., 2012). 
The duration of illness and the duration of untreated psychosis (DUP) were also assessed. 
Any participant who had a neurological illness; a history of traumatic brain injury with 
loss of consciousness; alcohol or drug abuse; or any physical illness, such as hepatitis, 
brain tumor, or epilepsy was excluded from the study. Healthy subjects were screened 
with the M.I.N.I. We excluded healthy participants with first- or second-degree relative(s) 
with a history of psychiatric disorders. Premorbid IQs were estimated using the Japanese 
version of the National Adult Reading Test (Matsuoka et al., 2006). The Global 
Assessment of Functioning scale (American Psychiatric Association, 2000) was used to 
assess social functioning. 
2.2 Emotional go/no-go task 
In fMRI studies using an emotional go/no-go task to assess cognitive-emotional 
interference in patients with another psychiatric condition such as bipolar disorder (Hare 
et al., 2008; Todd et al., 2012; Wessa et al., 2007), go trials (target stimuli) occurred from 
50–70% of the trials. The stimuli were fearful, angry, and happy faces that were presented 
for 0.5 s with a 1- to 2-s interstimulus interval. Based on these studies and our pilot trials, 
we set the presentation of face stimuli for 1-s with a 1-s interstimulus interval considering 
the task difficulty for patients with SZ. We also adopted faces with negative emotions of 
fear and angry as emotional stimuli because those showed greater deficit of the face 
processing for negative emotions compared to that for positive emotion (Kohler 
2003AJP). The emotional go/no-go task consisted of go and no-go trials in emotional, 
non-emotional, and control blocks (Figure 1). The entire task took 404 s and consisted of 
five blocks, including one emotional block with emotional faces, one non-emotional 
block with neutral faces, and three control blocks with geometrical figures (Figure 1). For 
go trials, participants responded by pressing a button on a keypad with the index finger 
of their preferred hand as fast as possible when a given target stimulus (e.g., angry face) 
appeared. Participants were instructed to withhold pressing a button on no-go trials (e.g., 
fearful face). Go and no-go trials each comprised 50% of the task. The emotional and 
non-emotional blocks were placed between the control blocks. In the emotional block, 
face pictures of two negative emotional expressions (anger and fear) were used as stimuli, 
and one of them was the target emotion. The emotional block consisted of two types of 
emotional tasks using negative emotional faces: go-anger and no-go-fear or go-fear and 
no-go-anger. In the non-emotional block, participants were required to identify the sex of 
the neutral face pictures, and these also consisted of two types of non-emotional tasks 
(go-male and no-go-female or go-female and no-go-male). The presentation of stimuli, 
choice of target stimuli, and emotional and non-emotional go/no-go task order were 
administered in a counterbalanced order across subjects. We recorded participants’ 
accuracy rates and reaction times. As there were 32 trials in each activation block, 76 s 
were required for completion (Figure 1). The Japanese and Caucasian Facial Expressions 
of Emotion and Neutral Faces (Matsumoto and Ekman, 1988) were used as cue and 
response choice stimuli in the emotional and non-emotional blocks. The control block 
was a sensorimotor go/no-go task with the same instructions in which subjects responded 
to geometric shapes (square or circle).  
2.3 fNIRS measurement 
 We used a continuous-wave NIRS system (ETG-4000, Hitachi Medical Co., Japan) to 
collect fNIRS data. Relative changes in the concentrations of oxygenated and 
deoxygenated hemoglobin ([oxy-Hb] and [deoxy-Hb], respectively) were monitored 
using a 52-channel NIRS machine with 16 detectors and 17 emitters (Matsubara et al., 
2014). Relative [oxy-Hb] changes were estimated according to the Beer–Lambert law 
using the difference in absorption between the two wavelengths of near-infrared light 
(695 and 830 nm). The distance between pairs of emitter and detector probes was 3 cm, 
which measures approximately 2–3 cm beneath the scalp (Okada and Delpy, 2003; 
Toronov et al., 2001). The measured area between an emitter and detector probe was 
defined as a channel. The lowest probes were positioned along the Fp1–Fp2 line 
according to the international 10/20 system for electroencephalography. Probes were 
placed over the frontal and temporal areas. The time resolution was set at 0.1 s.  
The data were analyzed using the integral mode, in which the pre-task baseline during 
the control block was determined as the mean [oxy-Hb] during the 10 s just prior to the 
task period, the post-task baseline during the control block was determined as the mean 
[oxy-Hb] of the last 10 s in the post-task period, and the data between two baselines was 
linearly fitted. Similar to recent fNIRS studies (Takei et al., 2013; Takizawa et al., 2008) 
we employed the inferior 31 channels of 52 channels for statistical analysis. Acquired 
[oxy-Hb] changes were smoothed with a moving average method, and the duration of the 
moving average was set at 5 s. The channel records with low signal-to-noise ratios or 
motion artifacts were excluded by an expert on fNIRS (KM) who was unaware of the 
subject’s diagnosis and task performance. The correspondence between NIRS channels 
and brain regions was confirmed (Okamoto et al., 2004). We anatomically identified the 
location of channels using a virtual registration method with automated anatomical 
labeling (Tzourio-Mazoyer et al., 2002) that enables NIRS channel positions to be 
registered on the standard brain space (Tsuzuki et al., 2007). 
2.4 Statistical analysis 
2.4.1 Behavioral data 
 Chi-square test for sex and Student’s t-tests for age and education were used to compare 
demographic characteristics between patients with SZ and healthy subjects. Task 
performance was assessed by the false alarm error rate (number of incorrect response/all 
correct withholding to no-go trials), omission error rate (number of incorrect no 
response/all correct response to go trials), and reaction time (for correct hits) for each 
block condition. We performed two-way analysis of variance (ANOVA) with task as a 
within-factor and diagnosis as a between-factor at each behavioral parameter. In patients 
with SZ, correlation analysis was carried out to compare behavioral performance and 
clinical variables (i.e., duration of illness, the number of hospitalization, DUP, GAF, 
PANSS subscores, and CPZ-eq) between the two groups using Bonferroni-corrected 
Pearson correlation coefficients. We used SPSS software for Windows, version 16.0 
(SPSS, Inc., Chicago, IL) for statistical analyses. Differences were considered significant 
at 0.05. 
2.4.2 fNIRS 
For within-group comparison, we tested differences of mean [oxy-Hb] and [deoxy-Hb] 
changes at each channel by performing Student’s t-tests for each channel between the 
emotional and non-emotional blocks in patients with SZ and healthy subjects, respectively. 
We carried out a between-group comparison to examine the difference of mean [oxy-Hb] 
and [deoxy-Hb] changes for each channel by Student’s t-tests between the patients with 
SZ and healthy subjects in the emotional and non-emotional blocks, respectively. We also 
statistically analyzed differences in mean [oxy-Hb] and [deoxy-Hb] changes at different 
channels using two-way ANOVA with the task and diagnosis as the within- and between-
factors, respectively. Statistical significance was set at p < 0.05, and false discovery rate 
(FDR) correction for the multiple comparisons among 31 channels was performed as 
described previously for fNIRS studies (Singh and Dan, 2006). Among the patients with 
SZ, a Bonferroni-corrected Pearson correlation coefficient was calculated to investigate 
the relationships between different clinical variables and the mean [oxy-Hb] and [deoxy-
Hb] changes at the channels determined to be significant in the between-group 
comparison. 
3 Results 
3.1 Demographics and task performance 
 There were no significant differences in demographic variables between patients with 
SZ and healthy subjects except in years of education (Table 1). There was a significant 
interaction between task and diagnosis for both reaction time (F = 8.56, p = 0.005) and 
false alarm error rate (F = 8.33, p = 0.006) and a significant effect of task on reaction time 
(F = 107.7, p < 0.001), omission error rate (F = 31.8, p < 0.001) and false alarm error rate 
(F = 16.9, p < 0.001) (Table 2).  
 In patients with SZ, a higher false alarm error rate in the emotional go/no-go block was 
significantly positively correlated with the negative (r = 0.55, p = 0.02), disorganized (r
= 0.68, p < 0.01), and excitement factors of the PANSS (r = 0.73, p < 0.01) and negatively 
correlated with GAF scores (r = -0.55, p = 0.02). Reaction time was positively correlated 
with illness duration (r = 0.65, p < 0.01). In the non-emotional go/no-go block, a higher 
omission error rate was significantly positively correlated with the PANSS excitement 
factor (r = 0.62, p < 0.01), and the mean reaction time was positively correlated with 
negative PANSS factors (r = 0.60, p < 0.01) and negatively correlated with GAF scores 
(r = -0.52, p = 0.04). None of the behavioral parameters was significantly correlated with 
CPZ-eq. 
3.2 fNIRS 
 In the within-group comparison, healthy subjects showed significantly greater [oxy-Hb] 
increases in seven channels (#29, #37, #38, #39, #46, #48, and #49) during the emotional 
go/no-go block compared to the non-emotional go/no-go block, corresponding to the left 
inferior, superior, and left and right orbital frontal regions (Figure 2A and 2C, Table 3). 
Healthy subjects also showed a significant [deoxy-Hb] decrease in channel #47, estimated 
to be the right orbitofrontal region. Patients with SZ showed similar time courses of mean 
[oxyHb] changes during the emotional and non-emotional go/no-go blocks (Figure 2B), 
and we did not observe significant differences in [oxy-Hb] or [deoxy-Hb] changes 
between the two blocks. No other significantly different [oxy-Hb] or [deoxy-Hb] was 
observed at any channel between the emotional and non-emotional go/no-go blocks in 
healthy subjects or patients with SZ.  
In the between-group comparison, relative to healthy subjects, patients with SZ showed 
attenuated [oxy-Hb] increases in four channels (#37, #38, #42, #47, and #48) during the 
emotional go/no-go block; they corresponded to the left superior frontal, left middle 
temporal, and left and right orbitofrontal regions, respectively (Figure 3 and Table 4). No 
channel showed a significantly greater [oxy-Hb] increase in patients with SZ compared 
to healthy subjects. Patients with SZ showed significant [deoxy-Hb] increases at #39 
compared to healthy subjects, which was estimated to be the left middle frontal region. 
During the non-emotional go/no-go block, there was no significant difference of [oxy-
Hb] or [deoxy-Hb] between patients with SZ and healthy subjects.  
Two-way ANOVA revealed that [oxy-Hb] change showed a significant interaction 
between the task and diagnosis in channel #25 (F = 4.70, p = 0.03), #28 (F = 4.05, p= 
0.049), #37 (F = 7.73, p = 0.008), #38 (F = 12.6, p = 0.0008; F = 5.41), #47 (F = 4.88, p
= 0.03), #48 (F = 9.61, p = 0.003), and #49 (F = 5.10, p = 0.03) and a significant effect 
of task in # 36 (F = 4.85, p = 0.03), #37 (F = 5.50, p = 0.02), #38 (F = 5.41, p = 0.02), 
#45 (F = 6.63, p = 0.01), #46 (F = 6.42, p = 0.02), #49 (F = 5.85, p = 0.02), and #50 (F = 
5.49, p = 0.02). The significant interaction of # 38 and #48, corresponding to the left 
superior frontal and orbitofrontal regions, survived after FDR correction.  
The mean [oxy-Hb] in channel #48 with significance in the between-group comparison 
was significantly inversely correlated with the number of hospitalizations (r = -0.43, p = 
0.03) in patients with SZ, but it was not significant after multiple comparison correction. 
No other significantly different [oxy-Hb] or [deoxy-Hb] at any channel was correlated 
with clinical variables in the between-group comparison. 
4 Discussion 
4.1 Primary results of the study 
The results of the current study demonstrate that patients with SZ showed similar fronto-
temporal region activations for the non-emotional and emotional go/no-go tasks, whereas 
healthy subjects exhibited greater activation in the superior, inferior, and orbital frontal 
and middle temporal regions during the emotional task compared to the non-emotional 
go/no-go task. Compared to healthy subjects, patients with SZ showed blunted activations 
during the emotional go/no-go task in the superior and orbital frontal and temporal regions, 
with more pronounced decreases in the frontal regions. Reduced orbitofrontal region 
activation tended to be associated with more frequent hospitalizations in patients with SZ. 
Poorer behavioral performance was associated with more severe SZ. These findings 
suggest that dysfunction of fronto-temporal regions, particularly the superior and 
orbitofrontal regions, is associated with the interaction between abnormal processing of 
emotional facial expressions with negative valence and cognitive inhibition in patients 
with SZ, especially during the rapid selection of rule-based associations that override 
automatic emotional response tendencies. It is likely that such deficits are involved in the 
pathophysiology underlying emotional-cognitive complex deficits in patients with SZ, 
including social situations. 
4.2 Abnormal fronto-temporal function in response to emotional-cognitive stimuli 
in SZ 
The frontopolar region including a part of the superior frontal region was activated by 
emotional tasks in normal volunteers, such as rating one’s emotions in response to 
pictures of varying valence in contrast to the more posterior region activated by cognitive 
tasks such as those designed to engage action monitoring and attention (Amodio and Frith, 
2006). The orbital frontal regions were also activated during the withholding of a response 
(Horn et al., 2003), during emotional regulation processes (Beauregard et al., 2004), and 
under the affect-incongruent responses (i.e., responses to emotional faces that conflict 
with the automatic approach-avoidance reaction evoked by the emotional face, such as 
approach angry faces and avoid happy faces) (Roelofs et al. 2009).  
The superior temporal sulcus (STS) separates the superior temporal gyrus from the 
middle temporal gyrus, and the functional territory for the posterior STS is thought to 
inferiorly extend to at least the posterior middle temporal gyrus (Wible et al., 2012). STS 
activity increases in response to incongruence between actions and intentions established 
by a previous emotional expression (Wyk et al., 2009). STS activity appears to be more 
enhanced during selective attention to facial emotion than during attention to the face per 
se (Narumoto et al., 2001).  
The blunted activation of the superior frontal, orbitofrontal, and middle temporal regions 
during emotional face tasks was reported in previous studies of patients with SZ (Habel 
et al., 2010; Leitman et al., 2011; Li et al., 2010; Li et al., 2012). A meta-analysis of brain 
function during facial emotion perception tasks with any emotions demonstrates that 
patients with SZ, relative to control subjects, showed lower activation of superior frontal 
gyrus, parahippocampal gyrus/amygdala and middle occipital gyrus (Li et al., 2010). In 
other fMRI studies, patients with SZ, compared to healthy subjects, showed blunted 
activation of right superior frontal gyrus during a facial valence discrimination task using 
sad faces (Li et al., 2012), lower activation of inferior frontal gyrus adjacent to 
orbitofrontal gyrus, anterior cingulate and cuneus during an emotional discrimination task 
using fear faces and inferior frontal gyrus, middle temporal gyrus, superior temporal 
gyrus and other areas during the task using angry faces (Habel, et al., 2010) and blunted 
activation of orbitofrontal gyrus during a facial affect detection task using fear and anger 
faces as well as happy and sad faces (Leitman et al., 2011). The results of current study 
that patients with SZ showed blunted activation of superior frontal and orbitofrontal gyrus 
and middle temporal gyrus in response to emotional facial stimuli further supports 
previous findings. 
With regard to brain function underlying the interaction between emotional faces and 
cognitive control, an fMRI study in normal volunteers using an emotional go/no-go task 
with aversive distractor images revealed that the posterior middle temporal gyrus and 
angular gyrus exhibited larger activation for aversive distractor trials compared to neutral 
distractor trials, suggesting involvement of the middle temporal gyrus in impulse control 
evoked by emotional situations (Brown et al., 2012). An fMRI study of patients with SZ 
demonstrated that during an emotional go/no-go task using emotional words (i.e. positive, 
negative, and neutral words), the patients showed lower activation of the superior/middle 
frontal gyri and other areas in response to negative words. No significantly different 
activations were observed in response to positive words in contrast to neutral words, 
compared to healthy subjects (Vercammen, et al., 2012). The investigators also found that 
patients with SZ showed no differential activation during the negative emotional block 
relative to the neutral block and more activation of right middle frontal gyrus during the 
positive emotional block relative to the neutral block. They therefore suggested that SZ 
is associated with abnormal modulation of the neural response in dorsal regions during 
negative emotional and inhibition processes and more anterior regions during positive 
emotional and inhibition. These findings are agreement with the results of the present 
despite the use of different study designs, task paradigms, and imaging devices.  
We also found that poor activation of the orbitofrontal region during the task was 
modestly associated with a larger number of hospitalizations. The frequent number of 
hospitalizations was predicted by the high scores of psychotic symptoms, as well as male 
sex and younger age (Roick et al., 2004), and were related to social networks including 
relatives, friends, and mental health services (Holmes-Eber et al., 1990). This suggests 
that a larger number of hospitalizations is associated with more severe psychosis and 
poorer social connection, but this finding should be cautiously interpreted because the 
distribution for six hospitalizations and fewer was different from the distribution for more 
than six hospitalizations in the present study. However, blunted activation of the orbital 
frontal region may reflect illness severity and social isolation that lead to more frequent 
hospitalizations in patients with SZ.  
Combined with earlier findings, the results of our study suggest that aberrant activation 
of the superior and orbitofrontal and middle temporal regions are involved in the 
interaction between negatively emotional facial processing and cognitive inhibition, 
which is thought to underlie the pathophysiology of brain abnormalities in patients with 
SZ.  
4.3 Abnormal behavioral performance in schizophrenia 
Facial emotion discrimination studies have suggested that patients with SZ have 
difficulty rejecting non-target emotions and fail to correctly identifying the target emotion 
(Habel et al., 2010; Schneider et al., 2006; Seiferth et al., 2009). Although the task design 
in prior studies were not the same as the one used here, our result that patients with SZ 
had a higher false alarm error rate than healthy subjects during the emotional go/no-go 
task is in agreement with the facial emotion perception deficits of SZ. Our finding that 
the higher false alarm error rate in patients with SZ during the emotional task was 
negatively correlated with GAF scores also supports the hypothesis of impaired emotional 
cognitive interaction related to poor social functioning (Park et al., 2008) and negative 
symptoms (Chan et al., 2010). As such findings were not observed in the emotional verbal 
go/no-go task (Vercammen et al., 2012), the impairment in rejecting non-target emotions 
may be a characteristic of patients with SZ, which may lead to inappropriate or even 
delusional interpretation when the patients look at emotional faces of other people. 
Speculatively, this could result in decreased social interaction and withdrawal. 
4.4 Limitations 
We should mention some limitations of the study. First, patients with SZ were medicated 
during study participation, which may have affected the results. However, subjects at risk 
of psychosis (Seiferth et al., 2008) and unmedicated, unaffected siblings of SZ patients 
(Kee et al., 2004) have been shown to exhibit emotional perception deficits. Medicated 
patients did not differ from unmedicated patients regarding their behavioral performance 
of facial emotion perception in a meta-analysis (Kohler et al., 2010). The present study 
showed that CPZ-eq was not correlated with brain activation or task performance. 
Therefore, the medication likely affected the results of this study to some extent, but this 
effect is not likely to be significant. Secondly, we did not assess participant attention 
during the tasks using measurements such as sleepiness and fatigue scales, although we 
consistently observed the subjects while they performed the tasks. Still, subjective scales 
should be used in future studies. Thirdly, we did not evaluate the behavioral and fNIRS 
data in the control block (the geometric sensorimotor go/no-go task). Some functional 
neuroimaging studies have demonstrated that patients with SZ exhibit deficits on this task 
(Arce et al., 2006; Kaladjian et al., 2007; Kiehl et al., 2000), whereas others did not 
(Laurens et al., 2003; Nishimura et al., 2011). As the control block in the current study 
was designed as a baseline task with a larger number of tasks per trial (108 stimuli) than 
that in non-emotional or emotional block (32 stimuli per trial), the behavioral and fNIRS 
data in the control block cannot be directly compared to those in the non-emotional or 
emotional block. If the difference in cognitive inhibition, emotional face processing, and 
the interaction of the two were to be assessed in a future investigation, a different study 
design would be required. Fourthly, the results should be cautiously interpreted because 
other brain regions that cannot be measured with fNIRS may be abnormally activated, 
which may impact on the fronto-temporal activation in patients with SZ. Prior fMRI 
studies demonstrated that patients with SZ showed abnormal function of the amygdala 
(Hall et al., 2008; Holt et al., 2006; Li et al., 2010) and parahippocampus (Li et al., 2010; 
Surguladze et al., 2006) during an emotional and neutral face task, and the anterior 
cingulate was abnormally activated during an emotional Stroop task (Park et al., 2008). 
The amygdala is a key player in emotional face processing (Haxby et al., 2000) and is 
activated in the emotional go/no-go task (Hare et al., 2008). The anterior cingulate 
connects with the dorsolateral and middle frontal regions and orbitofrontal cortex and is 
known to be involved in aspects of working memory, rule-based learning, attention, and 
emotional regulation (Bonelli et al., 2007). fNIRS cannot detect the activation of these 
regions because they are located deep in the brain; thus, the activation of these regions 
may have affected brain function and behavioral performance in the present study. Finally, 
as NIRS has a low spatial resolution (approximately 3 cm, which is roughly 1 gyrus of 
the brain) (Suda et al., 2011), anatomical identification in the present study is not as 
accurate as fMRI investigations. 
5. Conclusion 
This is the first fNIRS study to evaluate brain function during an emotional go/no-go 
task in patients with SZ. Our results suggest that patients with SZ exhibit blunted fronto-
temporal activation in response to the interaction task, suggesting that dysfunction of 
these brain regions is involved in the pathophysiology of abnormal emotional processing 
and cognitive inhibition in patients with SZ. These findings may further our 
understanding of impaired social interaction in patients with SZ. 
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Figure legends 
Figure 1. Task design of the emotional go/no-go task in fNIRS.  
Each block included two variations of facial information discrimination (E1 and E2 in the 
emotional block, NE1 and NE2 in the non-emotional block). The target stimuli for Go 
differ in each task. For example, in the emotional block, angry and fearful faces are the 
target stimuli of the E1 and E2 tasks, respectively. All of the blocks are 404 s. 
C, Control task; E, Emotional task; NE, Non-emotional task. 
Figure 2. Within-group comparison of mean [oxy-Hb] changes during the emotional and 
non-emotional go/no-go blocks in patients with SZ and healthy subjects. 
A: Red traces indicate [oxy-Hb] during the emotional block, and pink traces indicate 
[oxy-Hb] during the non-emotional block in healthy subjects. Orange boxes show 
channels with significant mean [oxy-Hb] changes between the emotional and non-
emotional go/no-go blocks in healthy subjects. B: Blue traces indicate [oxy-Hb] during 
the emotional blocks, and turquoise trace indicate [oxy-Hb] during the non-emotional 
blocks in patients with SZ. C: Orange circles with the channel number represent the 
location of the channels with significance in A, and white circles represent the location 
of non-significant channels. 
Figure 3. Between-group comparison of mean [oxy-Hb] changes during the emotional 
go/no-go blocks between patients with SZ and healthy subjects. 
A: Red traces indicate [oxy-Hb] in healthy subjects, and blue traces indicate [oxy-Hb] in 
patients with SZ during the emotional go/no-go block. Orange boxes show channels with 
significantly different mean [oxy-Hb] changes during the emotional blocks between 
patients with SZ and healthy subjects. B: Orange circles with the channel number 
represent the location of the channels with significance in A, and white circles represent 




(n = 25) p
Age (years) 40.1 ± 8.1 41.3 ± 9.2 0.62
Sex (m/f) 12/16 10/15 0.83
Educations (years) 15.9 ± 2.1 13.4 ± 2.3 <0.001
a  Handedness 86.1 ± 18.1 79.6 ± 39.3 0.44
b Estimated premorbid IQ 102.0 ± 6.4 99.4 ± 10.8 0.28
DUP (months) 14.6 ± 30.3
Duration of illness (years) 21.5 ± 11.0
PANSS five-factor model
  Positive factor 6.6 ± 3.0
  Negative factor 18.7 ± 7.7
  Disorganized/concrete factor 5.1 ± 2.6
  Excited factor 4.8 ± 2.6
  Depressed factor 4.0 ± 1.5
GAF 47.8 ± 17.9
CPZ-eq (mg/day) 981.6 ± 589.7
Data were given as mean ± sd. a Assessed using the Edinburgh Handedness Inventory.
b Assessed using the Japanese version of the National Adult Reading Test.
p  < 0.01 by Student's t-test
Table 1.  Demographic and clinical characteristics of participants.
DUP, duration of untreated psychosis; PANSS, Positive and Negative Syndrome Scale;
GAF, Global Assessment of Functioning; CPZ-eq, chlorpromazine-equivalents






